Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41a639aa11b9b2f8063a3e6b8b22b557 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-863 |
filingDate |
2011-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb452b3044b0695cc0c1d08d700ccd0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886612f3a279fc99fc3f2377d9059e92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f25e76d811873c655eeadaf275510e0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b7bf15238e966bde1adc7787b4cd83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45061efcac59be9250f1f30273ed925e |
publicationDate |
2013-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2618840-A2 |
titleOfInvention |
Recombinant viral vectors and methods for inducing an immune response to yellow fever virus |
abstract |
The present invention relates to recombinant viral vectors and methods of using the recombinant viral vectors to induce an immune response to yellow fever virus. The invention provides recombinant viral vectors based on the non-replicating modified vaccinia virus Ankara or based on a D4R-defective vaccinia virus. When administered according to methods of the invention, the recombinant viral vectors induce a broad immune response to yellow fever virus and demonstrate an excellent safety profile. |
priorityDate |
2010-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |